
AMWL Stock Forecast & Price Target
AMWL Analyst Ratings
Bulls say
American Well is showing positive signs of successfully reorienting towards its core technology platform solution and higher-quality recurring revenue, with strong quarterly financial results and raised EBITDA guidance. With a scaled physician network and wide range of services, the company is well positioned to gain share in the growing market for telehealth and virtual care. However, there are potential risks associated with the healthcare IT industry, such as government spending cuts and customer losses due to industry consolidation. Nevertheless, we believe American Well is well positioned for growth and organic growth may come in stronger than expected.
Bears say
American Well is facing risks to its growth and valuation if telehealth adoption is slower than expected among consumers, leading to potential delays in investments from health plan clients. However, the company's strong familiarity and positive patient experiences with telehealth indicate a high likelihood of repeat utilization. Additionally, the DHA contract is set to be renewed in summer 2026, and if reinstated, could provide meaningful revenue upside. The company is also focused on shifting its business to a SaaS-based model and divesting non-core assets.
This aggregate rating is based on analysts' research of American Well Corporation and is not a guaranteed prediction by Public.com or investment advice.
AMWL Analyst Forecast & Price Prediction
Start investing in AMWL
Order type
Buy in
Order amount
Est. shares
0 shares